Safety of medicines during breastfeeding – from case report to modeling: a contribution from the ConcePTION project

References

• Saha MR, Ryan K, Amir LH. Postpartum women’s use of medicines and breastfeeding practices: a systematic review. Int Breastfeed J. 2015;10(1):28. DOI:10.1186/s13006-015-0053-6.
   PubMedGoogle Scholar
• Anderson PO, Manoguerra AS, Valdés V. A review of adverse reactions in infants from medications in breastmilk. Clin Pediatr (Phila). 2016Mar; 55(3): 236–244. 10.1177/0009922815594586.
   PubMed Web of Science ®Google Scholar
• Anderson PO, Pochop SL, Manoguerra AS. Adverse drug reactions in breastfed infants: less than imagined. Clin Pediatr (Phila). 2003May; 42(4): 325–340. 10.1177/000992280304200405.
   PubMed Web of Science ®Google Scholar
• Drugs and Lactation Database (LactMed) 2006. [cited 2022 Sep 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/
   Google Scholar
• Akus M, Bartick M. Lactation safety recommendations and reliability compared in 10 medication resources. Ann Pharmacother. 2007Sep; 41(9): 1352–1360. 10.1345/aph.1K052.
   PubMed Web of Science ®Google Scholar
• Briggs GG, Forinash AB, Towers CV . Briggs drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Lippincott Williams & Wilkins; 2021.
   Google Scholar
• Mazer-Amirshahi M, Samiee-Zafarghandy S, Gray G, et al. Trends in pregnancy labeling and data quality for US-approved pharmaceuticals. Am J Obstet Gynecol. 2014 Dec;211(6):690.e1–11.
   PubMed Web of Science ®Google Scholar
• Anderson PO. Medication information sources for breastfeeding mothers. Breastfeed Med. 2017Sep; 12(7): 396–397. 10.1089/bfm.2017.0110.
   PubMed Web of Science ®Google Scholar
• Schirm E, Schwagermann MP, Tobi H, et al. Drug use during breastfeeding. A survey from the Netherlands. Eur J Clin Nutr. 2004 Feb;58(2):386–390.
   PubMed Web of Science ®Google Scholar
• Del Ciampo LA, Del Ciampo IRL. Breastfeeding and the benefits of lactation for women’s health. Rev Bras Ginecol Obstet. 2018Jun; 40(6): 354–359. 10.1055/s-0038-1657766.
   PubMedGoogle Scholar
• Binns C, Lee M, Low WY. The long-term public health benefits of breastfeeding. Asia Pac J Public Health. 2016Jan; 28(1): 7–14. 10.1177/1010539515624964.
   PubMed Web of Science ®Google Scholar
• ConcePTION [cited 2022 Sep 1]. Available from: https://www.imi-conception.eu/.
   Google Scholar
• Illamola SM, Bucci-Rechtweg C, Costantine MM, et al. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives. Br J Clin Pharmacol. 2018 Feb;84(2):215–222.
   PubMed Web of Science ®Google Scholar
• Weld ED, Bailey TC, Waitt C. Ethical issues in therapeutic use and research in pregnant and breastfeeding women. Br J Clin Pharmacol. 2022 Jan;88(1):7–21.
   PubMed Web of Science ®Google Scholar
• PRGLAC - Task Force on Research Specific to Pregnant Women and Lactating Women. 2018 [cited 2023 Jan 26]. Available from: https://www.nichd.nih.gov/about/advisory/PRGLAC. :
   Google Scholar
• Nooney J, Thor S, de Vries C, et al. Assuring access to safe medicines in pregnancy and breastfeeding. Clin Pharmacol Ther. 2021 Oct;110(4):941–945.
   PubMed Web of Science ®Google Scholar
• Eke AC, Olagunju A, Momper J, et al. Optimizing pharmacology studies in pregnant and lactating women using lessons from HIV: a consensus statement. Clin Pharmacol Ther. 2021 Jul;110(1):36–48.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. PregnAncy and lactation labeling (Drugs) final rule. 2015 [cited 2022 Sep 4]. Available from: https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule
   Google Scholar
• Dinatale M, Roca C, Sahin L, et al. The importance of clinical research in pregnant women to inform prescription drug labeling. J Clin Pharmacol. 2020 Dec;60(S2):S18–s25.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Clinical lactation studies: considerations for study design. Guidance for Industry. 2019 [cited 2022 Jun 3]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-lactation-studies-considerations-study-design
   Google Scholar
• Jordan S, Bromley R, Damase-Michel C, et al. Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert. Int Breastfeed J. 2022 Aug 2;17(1):55. DOI:10.1186/s13006-022-00494-5
   PubMed Web of Science ®Google Scholar
• Anderson PO. Drugs in lactation. Pharm Res. 2018 Feb 6;35(3):45. DOI:10.1007/s11095-017-2287-z
   PubMed Web of Science ®Google Scholar
• Begg EJ, Duffull SB, Hackett LP, et al. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002 Nov;18(4):323–332.
   PubMedGoogle Scholar
• Verstegen RHJ, Ito S. Drugs in lactation. J Obstet Gynaecol Res. 2019Mar; 45(3): 522–531. 10.1111/jog.13899.
   PubMed Web of Science ®Google Scholar
• Ito N, Ito K, Ikebuchi Y, et al. Prediction of drug transfer into milk considering Breast Cancer Resistance Protein (BCRP)-mediated transport. Pharm Res. 2015 Aug;32(8):2527–2537.
   PubMed Web of Science ®Google Scholar
• Hale TW. Pharmacology review: drug therapy and breastfeeding: pharmacokinetics, risk factors, and effects on milk production. NeoReviews. 2004;5(4):e164–e172. DOI:10.1542/neo.5-4-e164.
   Google Scholar
• Fleishaker JC. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev. 2003 Apr 29;55(5):643–652. DOI:10.1016/S0169-409X(03)00032-2
   PubMed Web of Science ®Google Scholar
• Anderson PO, Sauberan JB. Modeling drug passage into human milk. Clin Pharmacol Ther. 2016Jul; 100(1): 42–52. 10.1002/cpt.377.
   PubMed Web of Science ®Google Scholar
• Oo CY, Kuhn RJ, Desai N, et al. Active transport of cimetidine into human milk. Clin Pharmacol Ther. 1995 Nov;58(5):548–555.
   PubMed Web of Science ®Google Scholar
• Atkinson HC, Begg EJ. Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet. 1990Feb; 18(2): 151–167. 10.2165/00003088-199018020-00005.
   PubMed Web of Science ®Google Scholar
• Anderson PO, Valdés V. Variation of milk intake over time: clinical and pharmacokinetic implications. Breastfeed Med. 2015Apr; 10(3): 142–144. 10.1089/bfm.2014.0170.
   PubMed Web of Science ®Google Scholar
• Yeung CHT, Fong S, Malik PRV, et al. Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models. Matern Child Nutr. 2020 Apr;16(2):e12938.
   PubMed Web of Science ®Google Scholar
• Hale TW. Hale’s medications & mothers’Milk 2022 [cited 2022 Jul 7]. Available from: https://www.halesmeds.com/mnemonics/47700
   Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med. 2003 Sep 18;349(12):1157–1167. DOI:10.1056/NEJMra035092
   PubMed Web of Science ®Google Scholar
• Gow PJ, Ghabrial H, Smallwood RA, et al. Neonatal hepatic drug elimination. Pharmacol Toxicol. 2001 Jan;88(1):3–15.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Bioanalytical Method Validation. Guidance for Industry. 2018 [cited 2022 Jun 3]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioanalytical-method-validation-guidance-industry
   Google Scholar
• Lin YS, Thummel KE, Thompson BD, et al. Sources of Interindividual Variability. Methods Mol Biol. 2021;2342:481–550.
   PubMedGoogle Scholar
• van den Anker J, Reed MD, Allegaert K, et al. Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 2018 Oct;58(Suppl_10):S10–s25.
   PubMed Web of Science ®Google Scholar
• Yalçin N, Flint RB, van Schaik RHN, et al. The impact of pharmacogenetics on pharmacokinetics and pharmacodynamics in neonates and infants: a systematic review. Pharmgenomics Pers Med. 2022;15:675–696. DOI:10.2147/PGPM.S350205
   PubMed Web of Science ®Google Scholar
• Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014 Apr 23;7(1):264. DOI:10.1186/1756-0500-7-264
   PubMedGoogle Scholar
• Anderson PO. Guidelines for reporting cases of medication use during lactation. Breastfeed Med. 2022 Feb;17(2):93–97.
   PubMed Web of Science ®Google Scholar
• Urso R, Blardi P, Giorgi G. A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci. 2002 Mar;6(2–3):33–44.
   PubMedGoogle Scholar
• Gabrielsson J, Weiner D. Non-compartmental analysis. Methods Mol Biol. 2012;929:377–389.
   PubMedGoogle Scholar
• Jamei M, Dickinson GL, Rostami-Hodjegan A. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of ‘bottom-up’ vs ‘top-down’ recognition of covariates. Drug Metab Pharmacokinet. 2009;24(1):53–75. DOI:10.2133/dmpk.24.53.
   PubMed Web of Science ®Google Scholar
• Julious SA, Debarnot CA. Why are pharmacokinetic data summarized by arithmetic means? J Biopharm Stat. 2000Feb; 10(1): 55–71. 10.1081/BIP-100101013.
   PubMedGoogle Scholar
• Charles B. Population pharmacokinetics: an overview. Aust Prescr. 2014;37(6):210–213. DOI:10.18773/austprescr.2014.078.
   Google Scholar
• Ette EI, Williams PJ. Population pharmacokinetics I: background, concepts, and models. Ann Pharmacother. 2004Oct; 38(10): 1702–1706. 10.1345/aph.1D374.
   PubMed Web of Science ®Google Scholar
• Beal SL, Sheiner LB, Boeckmann A, et al. NONMEM 7.4 users guides 1989-2018. Available from: https://nonmem.iconplc.com/nonmem743/guides
   Google Scholar
• MONOLIXSuite. Version 2021R2. Antony,France: Lixoft SAS; 2021.
   Google Scholar
• Phoenix. Version 8.3. Princeton,(NJ): Certara; 2020.
   Google Scholar
• Fidler M, Wilkins JJ, Hooijmaijers R, et al. Nonlinear mixed-effects model development and simulation using nlmixr and related R open-source packages. CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):621–633.
   PubMedGoogle Scholar
• Guidi M, Csajka C, Buclin T. Parametric approaches in population pharmacokinetics. J Clin Pharmacol. 2022Feb; 62(2): 125–141. 10.1002/jcph.1633.
   PubMed Web of Science ®Google Scholar
• Goutelle S, Woillard JB, Buclin T, et al. Parametric and nonparametric methods in population pharmacokinetics: experts’ discussion on use, strengths, and limitations. J Clin Pharmacol. 2022 Feb;62(2):158–170.
   PubMed Web of Science ®Google Scholar
• Weisskopf E, Guidi M, Fischer CJ, et al. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: prediction of infant drug exposure through breast milk. Br J Clin Pharmacol. 2020 Aug;86(8):1642–1653.
   PubMed Web of Science ®Google Scholar
• Samara E, Granneman R. Role of population pharmacokinetics in drug development. Clin Pharmacokinet. 1997;32(4):294–312. doi:10.2165/00003088-199732040-00003
   PubMed Web of Science ®Google Scholar
• Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit–a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005Sep; 79(3): 241–257. 10.1016/j.cmpb.2005.04.005.
   PubMed Web of Science ®Google Scholar
• Bergstrand M, Hooker AC, Wallin JE, et al. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. Aaps J. 2011 Jun;13(2):143–151.
   PubMed Web of Science ®Google Scholar
• Brendel K, Dartois C, Comets E, et al. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet. 2007;46(3):221–234. DOI:10.2165/00003088-200746030-00003
   PubMed Web of Science ®Google Scholar
• Keizer RJ, Ter Heine R, Frymoyer A, et al. Model-informed precision dosing at the bedside: scientific challenges and opportunities. CPT Pharmacometrics Syst Pharmacol. 2018 Dec;7(12):785–787.
   PubMedGoogle Scholar
• Panchaud A, Garcia-Bournissen F, Csajka C, et al. Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure. Clin Pharmacol Ther. 2011 Jun;89(6):830–836.
   PubMed Web of Science ®Google Scholar
• Mahmood I, Tegenge MA. A comparative study between allometric scaling and physiologically based pharmacokinetic modeling for the prediction of drug clearance from neonates to adolescents. J Clin Pharmacol. 2019Feb; 59(2): 189–197. 10.1002/jcph.1310.
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24(1):25–36. DOI:10.2133/dmpk.24.25.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Clinical lactation studies – study design, data analysis, and recommendations for labeling. Guidance for Industry. 2005.
   Google Scholar
• Zhuang X, Lu C. PBPK modeling and simulation in drug research and development. Acta Pharm Sin B. 2016Sep; 6(5): 430–440. 10.1016/j.apsb.2016.04.004.
   PubMed Web of Science ®Google Scholar
• Job KM, Dallmann A, Parry S, et al. Development of a generic physiologically-based pharmacokinetic model for lactation and prediction of maternal and infant exposure to ondansetron via breast milk. Clin Pharmacol Ther. 2022 May;111(5):1111–1120.
   PubMed Web of Science ®Google Scholar
• Nauwelaerts N, Deferm N, Smits A, et al. A comprehensive review on non-clinical methods to study transfer of medication into breast milk - a contribution from the ConcePTION project. Biomed Pharmacother. 2021 Apr;136:111038.
   PubMed Web of Science ®Google Scholar
• Abduljalil K, Pansari A, Ning J, et al. Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically-based pharmacokinetic model. CPT Pharmacometrics Syst Pharmacol. 2021 Aug;10(8):878–889.
   PubMedGoogle Scholar
• Jones HM, Gardner IB, Collard WT, et al. Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 2011 May;50(5):331–347.
   PubMed Web of Science ®Google Scholar
• Corley RA, Mast TJ, Carney EW, et al. Evaluation of physiologically based models of pregnancy and lactation for their application in children’s health risk assessments. Crit Rev Toxicol. 2003;33(2):137–211. DOI:10.1080/713611035
   PubMed Web of Science ®Google Scholar
• Smits A, De Cock P, Vermeulen A, et al. Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute. Expert Opin Drug Metab Toxicol. 2019;15(1):25–34. 2019/01/02. doi:10.1080/17425255.2019.1558205.
   PubMed Web of Science ®Google Scholar
• Yeung CHT, Ito S, Autmizguine J, et al. Incorporating breastfeeding-related variability with physiologically based pharmacokinetic modeling to predict infant exposure to maternal medication through breast milk: a workflow applied to lamotrigine. Aaps J. 2021 May 17;23(4):70. DOI:10.1208/s12248-021-00599-5
   PubMed Web of Science ®Google Scholar
• Olagunju A, Rajoli R, Atoyebi S, et al. Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding. AAS Open Research. 05/14 2018;1:16.
   Google Scholar
• van Groen BD, Nicolaï J, Kuik AC, et al. Ontogeny of hepatic transporters and drug-metabolizing enzymes in humans and in nonclinical species. Pharmacol Rev. 2021 Apr;73(2):597–678.
   PubMed Web of Science ®Google Scholar
• Rao N. The clinical pharmacokinetics of escitalopram. Clin Pharmacokinet. 2007;46(4):281–290. DOI:10.2165/00003088-200746040-00002.
   PubMed Web of Science ®Google Scholar
• Delaney SR, Malik PRV, Stefan C, et al. Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques. Clin Pharmacokinet. 2018 Dec;57(12):1603–1611.
   PubMed Web of Science ®Google Scholar
• Rampono J, Hackett LP, Kristensen JH, et al. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. Br J Clin Pharmacol. 2006 Sep;62(3):316–322.
   PubMed Web of Science ®Google Scholar
• Johnson TN, Rostami-Hodjegan A. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anaesth. 2011Mar; 21(3): 291–301. 10.1111/j.1460-9592.2010.03323.x.
   PubMed Web of Science ®Google Scholar
• Jamei M. Recent advances in development and application of Physiologically-Based Pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance. Curr Pharmacol Rep. 2016;2(3):161–169. DOI:10.1007/s40495-016-0059-9.
   PubMedGoogle Scholar
• Geraghty SR, Davidson BS, Warner BB, et al. The development of a research human milk bank. J Hum Lact. 2005 Feb;21(1):59–66.
   PubMed Web of Science ®Google Scholar
• Ostler MW, Porter JH, Buxton OM. Dried blood spot collection of health biomarkers to maximize participation in population studies. J Vis Exp. 2014Jan; 28(83): e50973. 10.3791/50973-v.
   Google Scholar
• Gupta K, Mahajan R. Applications and diagnostic potential of dried blood spots. Int J Appl Basic Med Res. 2018Jan; 8(1): 1–2. 10.4103/ijabmr.IJABMR_7_18.
   PubMedGoogle Scholar
• Jesús VR D, Mei JV, Bell CJ, et al. Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the centers for disease control and prevention. Semin Perinatol. 2010 Apr;34(2):125–133.
   PubMed Web of Science ®Google Scholar
• Demirev PA. Dried blood spots: analysis and applications. Anal Chem. 2013 Jan 15;85(2):779–789. DOI:10.1021/ac303205m
   PubMed Web of Science ®Google Scholar
• Allegaert K, Simons SHP, Tibboel D, et al. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: filling the gaps beyond developmental pharmacology. Eur J Pharm Sci. 2017 Nov 15;109:S27–s31. DOI:10.1016/j.ejps.2017.05.023
   Web of Science ®Google Scholar
• Roque Pereira L, Durán CE, Layton D, et al. A landscape analysis of post-marketing studies registered in the EU PAS regIster and clinicaltrials.gov focusing on pregnancy outcomes or breastfeeding effects: a contribution from the conception project. Drug Saf. 2022;45(4):333–344. 2022/04/01. doi:10.1007/s40264-022-01154-7.
   PubMed Web of Science ®Google Scholar